enGene Therapeutics Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
1.700
+0.010 (0.59%)
Aug 14, 2026, 1:50 PM EDT - Market open
enGene Therapeutics Market Cap
enGene Therapeutics has a market cap or net worth of $113.88 million as of August 14, 2026. Its market cap has decreased by -38.44% in one year.
Market Cap
113.88M
Enterprise Value
-111.23M
1-Year Change
-38.44%
Ranking
Category
Stock Price
$1.70
ChartMarket Cap Chart
Since February 1, 2022, enGene Therapeutics's market cap has decreased from $155.91M to $113.88M, a decrease of -26.96%. That is a compound annual growth rate of -6.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 113.88M | -81.17% |
| Dec 31, 2025 | 604.87M | 78.43% |
| Dec 31, 2024 | 338.99M | 58.32% |
| Dec 29, 2023 | 214.12M | 31.08% |
| Dec 30, 2022 | 163.34M | 4.77% |
| Feb 1, 2022 | 155.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Indaptus Therapeutics | 122.30M |
| Yarrow Bioscience | 120.83M |
| Black Diamond Therapeutics | 117.78M |
| Seer, Inc. | 117.27M |
| Vivani Medical | 116.85M |
| Cue Biopharma | 115.13M |
| Nautilus Biotechnology | 113.26M |
| Genelux | 113.02M |